• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Hill-Rom and EarlySense Launch Smart Hospital Bed w/ Integrated Monitoring Technology

by Fred Pennic 12/11/2018 Leave a Comment

Hill-Rom and EarlySense Launch Smart Hospital Bed w/ Integrated Monitoring Technology

Hill-Rom, a global provider of medical technologies and the world’s leading hospital bed manufacturer, today announced that EarlySense, the market leader in contact-free continuous monitoring solutions across the care continuum, has integrated its continuous contact-free heart rate and respiratory rate sensing and analytics technology into Hill-Rom’s Centrella® Smart+ bed platform.

The Rise of the Smart Hospital Bed

The hospital bed -a consistent fixture in every hospital room- now takes on an important medical care role, alerting staff to engage at the earliest warning signs of risk when care is most effective. The Centrella bed, which offers optimized patient safety, enhanced patient satisfaction and advanced caregiver-focused technology, now allows for continuous monitoring of patients’ heart and respiratory rates over 100 times per minute without ever touching the patient. EarlySense technology alerts clinicians to potential patient deterioration events much earlier than traditional monitoring methods, enabling health teams to intervene and avoid “failure to rescue” scenarios more effectively.

Centrella Bed Results/Outcomes

Specific improved clinical outcomes demonstrated with this technology include helping reduce mortality related to “code blue” events by 83 percent1, and cardiac arrests by 86 percent.2 In addition, clinicians reported overall hospital length-of-stay was reduced by 9 percent2 and ICU days by 45 percent.2 Several EarlySense customers have reported that the system also assisted with early detection of sepsis, a condition that, when not identified and treated rapidly, may be life-threatening.

“No patient should deteriorate without prior warning in the hospital environment. Continuous vital signs measurement should be the standard of clinical practice in the United States,” said Dr. Frank Overdyk, a Charleston, SC-based anesthesiologist and expert on respiratory compromise. “Events such as opioid-induced respiratory depression and loss of life from failure-to-rescue are no longer acceptable given the availability of continuous vital signs monitoring.”

 

Tagged With: Artificial Intelligence, Continuous Vital Sign Monitoring, Machine Learning, Smart Hospital Bed

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |